Lazard Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Sell |
7,744
-13,946
| -64% | -$23.4K | ﹤0.01% | 2150 |
|
|
2025
Q1 | $72K | Buy |
21,690
+21,625
| +33,269% | +$71.8K | ﹤0.01% | 1905 |
|
|
2024
Q4 | $0 | Hold |
65
| – | – | ﹤0.01% | 2403 |
|
|
2024
Q3 | $0 | Sell |
65
-161
| -71% | – | ﹤0.01% | 2360 |
|
|
2024
Q2 | $1K | Sell |
226
-3,642
| -94% | -$16.1K | ﹤0.01% | 2152 |
|
|
2024
Q1 | $56K | Sell |
3,868
-2,133
| -36% | -$30.9K | ﹤0.01% | 1699 |
|
|
2023
Q4 | $48K | Buy |
6,001
+2,320
| +63% | +$18.6K | ﹤0.01% | 1894 |
|
|
2023
Q3 | $16K | Buy |
3,681
+146
| +4% | +$635 | ﹤0.01% | 2121 |
|
|
2023
Q2 | $24K | Buy |
3,535
+114
| +3% | +$774 | ﹤0.01% | 2068 |
|
|
2023
Q1 | $20K | Buy |
3,421
+699
| +26% | +$4.09K | ﹤0.01% | 2055 |
|
|
2022
Q4 | $17K | Sell |
2,722
-770
| -22% | -$4.81K | ﹤0.01% | 2152 |
|
|
2022
Q3 | $32K | Buy |
3,492
+18
| +0.5% | +$165 | ﹤0.01% | 1968 |
|
|
2022
Q2 | $37K | Buy |
3,474
+117
| +3% | +$1.25K | ﹤0.01% | 1939 |
|
|
2022
Q1 | $55K | Buy |
3,357
+934
| +39% | +$15.3K | ﹤0.01% | 1695 |
|
|
2021
Q4 | $46K | Buy |
2,423
+425
| +21% | +$8.07K | ﹤0.01% | 1777 |
|
|
2021
Q3 | $48K | Sell |
1,998
-1,008
| -34% | -$24.2K | ﹤0.01% | 1699 |
|
|
2021
Q2 | $77K | Buy |
3,006
+2,945
| +4,828% | +$75.4K | ﹤0.01% | 1424 |
|
|
2021
Q1 | $1K | Hold |
61
| – | – | ﹤0.01% | 1826 |
|
|
2020
Q4 | $2K | Buy |
+61
| New | +$2K | ﹤0.01% | 1806 |
|